Do all patients with head and neck cancer benefit from radiotherapy and concurrent cetuximab?

Jesper Grau Eriksen, Pernille Lassen, Jens Overgaard

Research output: Contribution to journalLetterResearchpeer-review

Original languageEnglish
JournalLancet Oncology
Volume11
Issue number4
Pages (from-to)312-3
Number of pages2
ISSN1470-2045
DOIs
Publication statusPublished - Apr 2010

Keywords

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • Biological Markers
  • Combined Modality Therapy
  • Head and Neck Neoplasms
  • Humans
  • Male
  • Neoplasm Proteins
  • Papillomavirus Infections
  • Patient Selection

Cite this